We are live on ! Find out more
PALI icon

Palisade Bio

15 hedge funds and large institutions have $242K invested in Palisade Bio in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more capital invested

Capital invested by funds: $86.6K → $242K (+$156K)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

25% more funds holding

Funds holding: 1215 (+3)

0.11% more ownership

Funds ownership: 0.11%0.22% (+0.11%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

PALI Hedge Fund Activity: Q4 2023 in Review

15 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2023, worth a combined $242K — up 180% from $86.6K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PALI positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $31.9K. The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $5.41K sold.

  • 15 institutional investors held Palisade Bio (PALI) as of Q4 2023, up from 12 in Q3 2023.
  • Funds reported $242K of Palisade Bio stock for Q4 2023, up 180% quarter-over-quarter.
  • 5 funds opened new Palisade Bio positions in Q4 2023 and 2 closed out, a net change of +3 holders.
  • The largest Palisade Bio buyer in Q4 2023 was Renaissance Technologies, an estimated $31.9K added.
  • The largest Palisade Bio seller in Q4 2023 was Baader Bank Aktiengesellschaft, an estimated $5.41K sold.

Based on aggregated 13F filings for Q4 2023.